Johnson & Johnson Aktie
| 227,24USD | 0,01USD | 0,00% |
WKN: 853260 / ISIN: US4781601046
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 141 700 | 152 700 | 131 900 | 139 800 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,66 | 0,62 | 0,65 | 0,64 | 0,00 |
Bilanz (in Mio. USD) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 60 979 | 55 294 | 53 495 | 55 893 | 0 |
| Summe Anlagevermögen | 121 039 | 132 084 | 114 063 | 124 211 | 0 |
| Summe Aktiva | 182 018 | 187 378 | 167 558 | 180 104 | 0 |
Bilanz (in Mio. USD) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 107 995 | 110 574 | 98 784 | 108 614 | 0 |
| Summe Eigenkapital | 74 023 | 76 804 | 68 774 | 71 490 | 0 |
| Summe Passiva | 182 018 | 187 378 | 167 558 | 180 104 | 0 |
Adresse
| One Johnson & Johnson Plaza, 08933 New Brunswick | |
| Telefon | +1 (732) 524-0400 |
| Internet | http://www.jnj.com |
Management
|
Anne M. Mulcahy
Independent Director |
|
Daniel E. Pinto
Director |
|
Darren Snellgrove
Vice President-Investor Relations |
|
Elizabeth Forminard
Chief Legal Officer & Executive Vice President |
|
Eugene A. Woods
Independent Director |
|
George Davy
Director-Global Human Resources |
|
Hubert Joly
Independent Director |
|
James D. Swanson
Chief Information Officer & Executive VP |
|
Jennifer A. Doudna
Independent Director |
|
Jennifer L. Taubert
EVP & Worldwide Chairman-Innovative Medicine |
|
Jessica Moore
Group Chief Financial Officer-Innovative Medicine |
|
Joaquin Duato
Chairman & Chief Executive Officer |
|
John C. Reed
Executive Vice President-Innovative Medicine |
|
John George Morikis
Independent Director |
|
Jonathan Sheh
Director-Workplace Experience |
|
Joseph J. Wolk
Chief Financial Officer & Executive Vice President |
|
Juliana Clawson
Head-Organization Change Management |
|
Kathryn E. Wengel
Chief Technical Operations & Risk Officer |
|
Kristen Blair Mulholland
Chief Human Resources Officer & Executive VP |
|
Marc Larkins
Secretary & Vice President-Governance |
|
Marillyn A. Hewson
Lead Independent Director |
|
Mark Alan Weinberger
Independent Director |
|
Mark B. McClellan
Independent Director |
|
Mary C. Beckerle
Independent Director |
|
Michael Bzdak
Global Dir-Employee Engagement-Global Cmnty Impact |
|
Nadja Y. West
Independent Director |
|
Paula A. Johnson
Independent Director |
|
Penny M. Heaton
Chief Medical Officer |
|
Robert J. Decker
Chief Accounting Officer & Controller |
|
Ronald A. Kapusta
Chief Accounting Officer & Controller |
|
Thomas J. Spellman
Secretary |
|
Timothy Schmid
Executive Vice President & Chairman-Worldwide |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.